Mylan Pharms. Inc. v. Sanofi-Aventis Deutschland Gmbh, IPR2018-01670 (PTAB) Sept. 10, 2018 N/A Lantus® SoloStar® (insulin glargine recombinant for injection), Apidra® SoloStar® (insulin glulisine ...
PARIS, Dec. 11, 2017 /PRNewswire/ -- The U.S. Food and Drug Administration (FDA) has approved Sanofi's Admelog ®, the first follow-on insulin lispro to help people living with diabetes manage blood ...
First FDA-approved follow-on mealtime insulin Admelog (insulin lispro injection) 100 Units/mL will be available in U.S. in vial and SoloStar pen Paris, France - December 11, 2017 - The U.S. Food and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results